Daily Care for December 4, 2019
advertisement
- FDA approves higher-dose insulin glargine for children with diabetes
- Exercise induced hypoglycaemia in type 1 diabetes (HTML)
- Factors predicting poor glycaemic control in the first two years of childhood onset type 1 diabetes in a cohort from East London, UK: Analyses using mixed effects fractional polynomial models (HTML)
- Continuous Glucose Monitor Use With Remote Monitoring Reduces Fear of Hypoglycemia in Pregnant Women With Type 1 Diabetes: A Pilot Study (HTML)
- Alarm Settings of CGM Systems Affect Glucose Control in T1D
- Exploring parental perspectives after commencement of flash glucose monitoring for type 1 diabetes in adolescents and young adults not meeting glycaemic targets: a qualitative study (HTML)
- Cost-effectiveness of long-acting insulin analogues versus intermediate/long-acting human insulin for type 1 diabetes: a population-based cohort following over 10 years (HTML)
- The role of theories in interventions targeting pre-teens with type 1 diabetes: A critical literature review (HTML)
- Special Considerations in the Systematic Psychosocial Screening of Youth with Type 1 Diabetes (HTML)
- Diabetes disclosure strategies in adolescents and young adult with type 1 diabetes
- Living with type 1 diabetes mellitus: How does the condition affect children’s and adolescents’ quality of life? (HTML)
- Diabetes Distress, Coping And Thriving
- Do-It-Yourself (DIY) Closed Loop Systems: Perspectives of an Endocrinologist (HTML)
- In Silico Trials of an Open-Source Android-Based Artificial Pancreqs: A New Paradigm to Test Safety and Efficacy of Do-It-Yourself Systems (HTML)
- Allergic contact dermatitis caused by isobornyl acrylate in OmniPod, an innovative tubeless insulin pump (HTML)
- Examining Potential Allergens in Adhesives Used for Diabetes Devices
